India
· Delayed Price · Currency is INR Gufic Biosciences Statistics
Total Valuation
Gufic Biosciences has a market cap or net worth of INR 41.98 billion. The enterprise value is 45.17 billion.
| Market Cap | 41.98B |
| Enterprise Value | 45.17B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | Sep 18, 2024 |
Share Statistics
Gufic Biosciences has 100.28 million shares outstanding. The number of shares has increased by 2.60% in one year.
| Shares Outstanding | 100.28M |
| Shares Change (YoY) | +2.60% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 44.46% |
| Owned by Institutions (%) | 5.60% |
| Float | 24.73M |
Valuation Ratios
The trailing PE ratio is 48.18.
| PE Ratio | 48.18 |
| Forward PE | n/a |
| PS Ratio | 5.11 |
| PB Ratio | 7.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 52.30 |
| EV / Sales | 5.55 |
| EV / EBITDA | 30.83 |
| EV / EBIT | 34.99 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 62.51 |
| Debt / EBITDA | 2.27 |
| Debt / FCF | n/a |
| Interest Coverage | 8.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 10.43% |
| Revenue Per Employee | 5.46M |
| Profits Per Employee | 579,267 |
| Employee Count | 1,491 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +34.85% |
| 50-Day Moving Average | 366.02 |
| 200-Day Moving Average | 333.84 |
| Relative Strength Index (RSI) | 61.09 |
| Average Volume (20 Days) | 22,917 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gufic Biosciences had revenue of INR 8.14 billion and earned 863.69 million in profits. Earnings per share was 8.69.
| Revenue | 8.14B |
| Gross Profit | 4.27B |
| Operating Income | 1.29B |
| Pretax Income | 1.16B |
| Net Income | 863.69M |
| EBITDA | 1.47B |
| EBIT | 1.29B |
| Earnings Per Share (EPS) | 8.69 |
Balance Sheet
The company has 134.84 million in cash and 3.33 billion in debt, giving a net cash position of -3.19 billion or -31.85 per share.
| Cash & Cash Equivalents | 134.84M |
| Total Debt | 3.33B |
| Net Cash | -3.19B |
| Net Cash Per Share | -31.85 |
| Equity (Book Value) | 5.33B |
| Book Value Per Share | 53.13 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.39%, with operating and profit margins of 15.85% and 10.60%.
| Gross Margin | 52.39% |
| Operating Margin | 15.85% |
| Pretax Margin | 14.21% |
| Profit Margin | 10.60% |
| EBITDA Margin | 17.99% |
| EBIT Margin | 15.85% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.60% |
| Shareholder Yield | -2.57% |
| Earnings Yield | 2.08% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 29, 2002. It was a forward split with a ratio of 10.
| Last Split Date | Oct 29, 2002 |
| Split Type | Forward |
| Split Ratio | 10 |